Corventum is a new medicines company committed to developing novel therapies that make cancer treatments safer and more effective. The company's lead program, CVT-130, is designed to prevent anthracycline-induced cardiotoxicity and improve outcomes for patients receiving these cornerstone chemothera... Read more
Employees
1-10Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
